Page 2 - Read Online
P. 2
Topic: Metastatic Renal Cell
Carcinoma
Special Issue Introduction
Chapter I. SYSTEMIC THERAPIES
Systemic Therapy for Metastatic Renal-Cell Carcinoma
Current and emerging therapies for first-line treatment of
metastatic clear cell renal cell carcinoma
Advances in second-line targeted therapies for metastatic
Dr Hendrik Van Poppel renal cell carcinoma
Immunotherapy for metastatic renal cell carcinoma
Management of Bone metastases of RCC: bone targeted
Dr Hendrik Van Poppel was the
Chairman of the Department of Urology treatment, radiotherapy
at the University Hospital Gasthuisberg, Treatment/ management of non-ccRCC
Katholieke Universiteit (KU) Leuven,
Belgium, from 2002 until 2015, and Chapter II. MOLECULAR EN BIOMARKERS
Co-Chair of the European Cancer An Update on Predictive Biomarkers in Metastatic Renal
Organisation’s Inequalities Network. Cell Carcinoma
He graduated in General Surgery in The Identification of Key Gene Expression Signature and
1980 and in Urology in 1983 and joined Biological Pathways in Metastatic Renal Cell Carcinoma
the Academic Unit at KU Leuven after Individualized therapy for metastatic renal cell carcinoma
his postgraduate training in London, Targeted genomic landscape of metastases compared
Barcelona, Copenhagen, Mainz and to primary tumours in clear cell metastatic renal cell
Rotterdam. In 1988, he obtained a carcinoma
PhD in Medical Sciences. He became
full Professor of Urology in 1993. He
developed the original surgical technique Chapter III. SURGERY
for prepubic urethrectomy, percutaneous Comparison of immediate vs deferred cytoreductive
gastrostomy, lumbal splenectomy during nephrectomy in patients with synchronous metastatic
orthotopic kidney transplantation, and renal cell carcinoma
of theLeuven “N”pouch for bladder Overview of adjuvant trials
substitution.
About value of metastasectomy
He has published more than 200 papers
as first author on uro-oncology and has Chapter IV. Other
co-authored more than 350 other ones The landscape of contemporary clinical trials for
and edited and co-edited several books untreated metastatic clear cell renal cell carcinoma
of kidney and prostate cancer. He was Imaging for Metastatic Renal Cell Carcinoma
Director of the European School of
Urology from 2004 to 2012 and Adjunct- Real-world outcomes of the treatment of metastatic renal
Secretary General of the European cell carcinoma
Association of Urology (EAU) responsible
for Education 2012-2021.
